Cargando…

Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes

Background: Different imaging techniques, such as echocardiography (ECHO) and CT, allow to assess aortic stenosis (AS) severity and could be used to study its progression. But only PET/CT open opportunities to assess activity of valvular inflammation and calcification in vivo. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Murtazalieva, Patimat, Ryzhkova, Darya, Malev, Eduard, Zhiduleva, Ekaterina, Moiseeva, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171046/
https://www.ncbi.nlm.nih.gov/pubmed/35685632
http://dx.doi.org/10.3389/fphar.2022.909975
_version_ 1784721574556860416
author Murtazalieva, Patimat
Ryzhkova, Darya
Malev, Eduard
Zhiduleva, Ekaterina
Moiseeva, Olga
author_facet Murtazalieva, Patimat
Ryzhkova, Darya
Malev, Eduard
Zhiduleva, Ekaterina
Moiseeva, Olga
author_sort Murtazalieva, Patimat
collection PubMed
description Background: Different imaging techniques, such as echocardiography (ECHO) and CT, allow to assess aortic stenosis (AS) severity and could be used to study its progression. But only PET/CT open opportunities to assess activity of valvular inflammation and calcification in vivo. The aim of this study was to assess prognostic value of valvular inflammation and calcification measured by (18)F-FDG and (18)F-NaF PET/CT in patients with tricuspid (TAV) and bicuspid aortic valve (BAV). Methods: The study included 71 patients aged 40–70 years with mild, moderate and severe asymptomatic calcific AS. Patients were divided into two groups according to valve morphology: with BAV and TAV. All patients underwent standard ECHO, CT calcium scoring PET/CT with (18)F-NaF and (18)F-FDG. All patients were evaluated during a follow-up visit with evaluation of ECHO parameters. (16.8 ± 4.2 months). Results: TAV and BAV groups were comparable in AS severity by ECHO (peak aortic jet velocity (Vmax): 2.90 [2.60; 3.50] vs. 2.96 [2.55; 3.31] m/s, p = 0.83). TBR max (18)F-FDG did not vary in TAV and BAV patients (1.15 [1.06; 1.23] vs. 1.11 [1.03; 1.20], p = 0.39). Both groups did not differ in valvular calcification degree (Agatston score 1,058 [440; 1798] vs. 1,128 [533; 2,360], p = 0.55) and calcification activity assessed by (18)F-NaF uptake level (TBR max 1.50 [1.30; 1.78] vs. 1.48 [1.27; 1.83], p = 0.97). (18)F-NaF TBR max was associated with AS severity measured by Vmax in men and women with TAV (r = 0.54; p = 0.04 vs. r = 0.53; p = 0.03). In BAV group this relationship was true only in female patients (r = 0.1; p = 0.67 vs. r = 0.7; p = 0.0004). There was no association between Vmax and TBR max (18)F-FDG was revealed in TAV and BAV groups. During follow-up period, the most important positive predictors of AS progression in TAV obtained by multinomial logistic regression analysis were Vmax, and (18)F-NaF TBR. Whereas in BAV the highest predictive value showed model included age and Vmax. Conclusion: (18)F-NaF PET/CT may be considered as the valuable predictor for hemodynamic progression of calcific AS in case of TAV. (18)F-FDG PET/CT does not play a significant role to predict the AS progression.
format Online
Article
Text
id pubmed-9171046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91710462022-06-08 Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes Murtazalieva, Patimat Ryzhkova, Darya Malev, Eduard Zhiduleva, Ekaterina Moiseeva, Olga Front Pharmacol Pharmacology Background: Different imaging techniques, such as echocardiography (ECHO) and CT, allow to assess aortic stenosis (AS) severity and could be used to study its progression. But only PET/CT open opportunities to assess activity of valvular inflammation and calcification in vivo. The aim of this study was to assess prognostic value of valvular inflammation and calcification measured by (18)F-FDG and (18)F-NaF PET/CT in patients with tricuspid (TAV) and bicuspid aortic valve (BAV). Methods: The study included 71 patients aged 40–70 years with mild, moderate and severe asymptomatic calcific AS. Patients were divided into two groups according to valve morphology: with BAV and TAV. All patients underwent standard ECHO, CT calcium scoring PET/CT with (18)F-NaF and (18)F-FDG. All patients were evaluated during a follow-up visit with evaluation of ECHO parameters. (16.8 ± 4.2 months). Results: TAV and BAV groups were comparable in AS severity by ECHO (peak aortic jet velocity (Vmax): 2.90 [2.60; 3.50] vs. 2.96 [2.55; 3.31] m/s, p = 0.83). TBR max (18)F-FDG did not vary in TAV and BAV patients (1.15 [1.06; 1.23] vs. 1.11 [1.03; 1.20], p = 0.39). Both groups did not differ in valvular calcification degree (Agatston score 1,058 [440; 1798] vs. 1,128 [533; 2,360], p = 0.55) and calcification activity assessed by (18)F-NaF uptake level (TBR max 1.50 [1.30; 1.78] vs. 1.48 [1.27; 1.83], p = 0.97). (18)F-NaF TBR max was associated with AS severity measured by Vmax in men and women with TAV (r = 0.54; p = 0.04 vs. r = 0.53; p = 0.03). In BAV group this relationship was true only in female patients (r = 0.1; p = 0.67 vs. r = 0.7; p = 0.0004). There was no association between Vmax and TBR max (18)F-FDG was revealed in TAV and BAV groups. During follow-up period, the most important positive predictors of AS progression in TAV obtained by multinomial logistic regression analysis were Vmax, and (18)F-NaF TBR. Whereas in BAV the highest predictive value showed model included age and Vmax. Conclusion: (18)F-NaF PET/CT may be considered as the valuable predictor for hemodynamic progression of calcific AS in case of TAV. (18)F-FDG PET/CT does not play a significant role to predict the AS progression. Frontiers Media S.A. 2022-05-24 /pmc/articles/PMC9171046/ /pubmed/35685632 http://dx.doi.org/10.3389/fphar.2022.909975 Text en Copyright © 2022 Murtazalieva, Ryzhkova, Malev, Zhiduleva and Moiseeva. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Murtazalieva, Patimat
Ryzhkova, Darya
Malev, Eduard
Zhiduleva, Ekaterina
Moiseeva, Olga
Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title_full Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title_fullStr Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title_full_unstemmed Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title_short Prediction of Aortic Stenosis Progression by (18)F-FDG and (18)F-NaF PET/CT in Different Aortic Valve Phenotypes
title_sort prediction of aortic stenosis progression by (18)f-fdg and (18)f-naf pet/ct in different aortic valve phenotypes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171046/
https://www.ncbi.nlm.nih.gov/pubmed/35685632
http://dx.doi.org/10.3389/fphar.2022.909975
work_keys_str_mv AT murtazalievapatimat predictionofaorticstenosisprogressionby18ffdgand18fnafpetctindifferentaorticvalvephenotypes
AT ryzhkovadarya predictionofaorticstenosisprogressionby18ffdgand18fnafpetctindifferentaorticvalvephenotypes
AT maleveduard predictionofaorticstenosisprogressionby18ffdgand18fnafpetctindifferentaorticvalvephenotypes
AT zhidulevaekaterina predictionofaorticstenosisprogressionby18ffdgand18fnafpetctindifferentaorticvalvephenotypes
AT moiseevaolga predictionofaorticstenosisprogressionby18ffdgand18fnafpetctindifferentaorticvalvephenotypes